NOW FDA approved for clinical use Measuring the APC Resistance associated with Factor V-L, quantitatively Second generation screenig assay for APC-R.
NEW CONCEPT FOR FV-LEIDEN Second generation for screening for APC-R. Reducing cost up to 50%/test compared to the old way of screening for APC-R. This new method is only available through Hyphen BioMed/Aniara.
For more information please follow the link below:
HEMOCLOT Quanti. V-L (ACK065L)kit is a clotting method proposed for measuring Factor V-L (Factor V Leiden) concentration in citrated plasma, by its resistance to the action of Activated Protein C (APC). The assay is performed in the presence of Activated Protein C. In presence of APC and Protein S (in excess), the prolongation of clotting time is directly related to the concentration of Normal Factor V, and inversely related to the amount of Factor V-Leiden (mutation R506Q).
.Quantitative reagent for measuring Factor V-L.
.No interference of plasma factor deficiencies (Other than that of Factor V).
.Excellent discrimination between Heterozygous, Homozygous and Normalís.
.Single test method performed with only a Clotting Time (CT).
Product SKU and Pricing Information
HEMOCLOT Quanti V-L 510K/CE Cleared Clotting Set of 3x20 tests ACK065K $225
Factor V-L Calibrator 510K/CE Cleared Set of 3 (4x1 ml) ASC065K $125
V-L CAL (Undiluted) 510K/CE Cleared 2x3x0.5 ml A222401 $125
BIOPHEN Normal Control Plasma 510k/CE Cleared 12x1 ml A223201 $175
Act PC-r Control Plasma 510K/CE Cleared 12x0.5 ml A223405 $195
Executive Vice President of Global Marketing and Sales
- Contact Information
- Jonas Kingo
- Aniara Diagnostica
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.